Loading...
XNAS
SXTC
Market cap1mUSD
Aug 28, Last price  
3.00USD
Name

China SXT Pharmaceuticals Inc

Chart & performance

D1W1MN
XNAS:SXTC chart
P/E
P/S
1.49
EPS
Div yield, %
Shrs. gr., 5y
88.21%
Rev. gr., 5y
-25.83%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
IPO date
Jan 04, 2019
Employees
88
Domiciled in
CN
Incorporated in
VG

Valuation

No data to show